Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002.
暂无分享,去创建一个
R. Abraham | C. Sabers | G. Brunn | G. Wiederrecht | J. Lawrence | Josie M. Williams | J. Williams | J. Williams | J. Williams | Robert T. Abrahaml | Candace J. Sabers
[1] R. Abraham. Phosphatidylinositol 3-kinase related kinases. , 1996, Current opinion in immunology.
[2] Takao Shimizu,et al. Wortmannin Inhibits Mitogen-activated Protein Kinase Activation by Platelet-activating Factor through a Mechanism Independent of p85/p110-type Phosphatidylinositol 3-Kinase (*) , 1996, The Journal of Biological Chemistry.
[3] M. Zvelebil,et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction , 1996, Molecular and cellular biology.
[4] A. Gingras,et al. Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. , 1996, The EMBO journal.
[5] M. Hall,et al. The TOR signalling pathway and growth control in yeast. , 1996, Biochemical Society transactions.
[6] R. Abraham,et al. Immunopharmacology of rapamycin. , 1996, Annual review of immunology.
[7] I. Stansfield,et al. An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast , 2012, Molecular biology of the cell.
[8] J. Heitman,et al. FKBP12‐rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol‐4 kinase activity. , 1995, The EMBO journal.
[9] N. Sonenberg,et al. Repression of cap‐dependent translation by 4E‐binding protein 1: competition with p220 for binding to eukaryotic initiation factor‐4E. , 1995, The EMBO journal.
[10] S. Schreiber,et al. PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints , 1995, Science.
[11] T. Hunter,et al. When is a lipid kinase not a lipid kinase? When it is a protein kinase , 1995, Cell.
[12] S. Schreiber,et al. Control of p70 S6 kinase by kinase activity of FRAP in vivo , 1995, Nature.
[13] R. Pearson,et al. Rapamycin, Wortmannin, and the Methylxanthine SQ20006 Inactivate p70s6k by Inducing Dephosphorylation of the Same Subset of Sites (*) , 1995, The Journal of Biological Chemistry.
[14] S. Snyder,et al. The Rapamycin and FKBP12 Target (RAFT) Displays Phosphatidylinositol 4-Kinase Activity (*) , 1995, The Journal of Biological Chemistry.
[15] V. Zakian. ATM-related genes: What do they tell us about functions of the human gene? , 1995, Cell.
[16] M. Connelly,et al. DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product , 1995, Cell.
[17] The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. , 1995, Molecular and cellular biology.
[18] P. Blackshear,et al. Control of PHAS-I by Insulin in 3T3-L1 Adipocytes , 1995, The Journal of Biological Chemistry.
[19] O. Hazeki,et al. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. , 1995, Trends in biochemical sciences.
[20] E. Krebs,et al. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Zon,et al. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. , 1995, Blood.
[22] Stuart L. Schreiber,et al. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin , 1995, Cell.
[23] J. Blenis,et al. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. , 1995, Cellular immunology.
[24] L. A. Burns,et al. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway , 1995, Molecular and cellular biology.
[25] J. Ding,et al. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils , 1995, The Journal of Biological Chemistry.
[26] R. Abraham,et al. Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.
[27] J. Blenis,et al. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.
[28] S. Emr,et al. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. , 1994, The Journal of biological chemistry.
[29] James M. Roberts,et al. lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.
[30] K. Kume,et al. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. , 1994, The Journal of biological chemistry.
[31] N. Sonenberg,et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. , 1994, Science.
[32] A. Gingras,et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.
[33] Paul Tempst,et al. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.
[34] J. Blenis,et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation , 1994, Molecular and cellular biology.
[35] Stuart L. Schreiber,et al. A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.
[36] J. Dodge,et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. , 1994, Cancer research.
[37] K Y Hui,et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.
[38] I Gout,et al. PI 3‐kinase is a dual specificity enzyme: autoregulation by an intrinsic protein‐serine kinase activity. , 1994, The EMBO journal.
[39] J. Kunz,et al. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. , 1994, Molecular biology of the cell.
[40] R. Abraham,et al. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes. , 1993, The Journal of biological chemistry.
[41] M. Mclaughlin,et al. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity , 1993, Molecular and cellular biology.
[42] J. Kunz,et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.
[43] E. Gelfand,et al. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle , 1993, Journal of cellular physiology.
[44] F. Nicoletti,et al. Characterization of specific binding sites for inositolhexakisphosphate in the anterior pituitary , 1993 .
[45] N. Sonenberg,et al. Remarks on the mechanism of ribosome binding to eukaryotic mRNAs. , 1993, Gene expression.
[46] C. Crews,et al. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[48] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[49] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[50] J. Heitman,et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.
[51] J. Hershey,et al. Translational control in mammalian cells. , 1991, Annual review of biochemistry.
[52] J. Herbert,et al. Characterization of specific binding sites for [3H]-staurosporine on various protein kinases. , 1990, Biochemical and biophysical research communications.
[53] N. Sigal,et al. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. , 1990, Journal of immunology.
[54] B. Sefton,et al. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. , 1989, Analytical biochemistry.
[55] U. Rüegg,et al. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. , 1989, Trends in pharmacological sciences.
[56] S. Ho,et al. Bioassay of interleukins , 1986 .